129 related articles for article (PubMed ID: 9751423)
21. Pretargeted radioimmunotherapy.
Meredith RF; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S57-9. PubMed ID: 16979441
[TBL] [Abstract][Full Text] [Related]
22. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity.
Kobayashi H; Sakahara H; Endo K; Yao ZS; Toyama S; Konishi J
Eur J Cancer; 1995 Sep; 31A(10):1689-96. PubMed ID: 7488426
[TBL] [Abstract][Full Text] [Related]
23. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
Hamblett KJ; Press OW; Meyer DL; Hamlin DK; Axworthy D; Wilbur DS; Stayton PS
Bioconjug Chem; 2005; 16(1):131-8. PubMed ID: 15656584
[TBL] [Abstract][Full Text] [Related]
24. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
[TBL] [Abstract][Full Text] [Related]
25. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates.
Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA
Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142
[TBL] [Abstract][Full Text] [Related]
26. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
[TBL] [Abstract][Full Text] [Related]
27. Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies.
Paganelli G; Pervez S; Siccardi AG; Rowlinson G; Deleide G; Chiolerio F; Malcovati M; Scassellati GA; Epenetos AA
Int J Cancer; 1990 Jun; 45(6):1184-9. PubMed ID: 2351490
[TBL] [Abstract][Full Text] [Related]
28. Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytin.
Alvarez-Diez TM; Polihronis J; Reilly RM
Nucl Med Biol; 1996 May; 23(4):459-66. PubMed ID: 8832700
[TBL] [Abstract][Full Text] [Related]
29. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
Sakahara H; Endo K; Nakashima T; Koizumi M; Kunimatsu M; Kawamura Y; Ohta H; Nakamura T; Tanaka H; Kotoura Y
J Nucl Med; 1987 Mar; 28(3):342-8. PubMed ID: 3469333
[TBL] [Abstract][Full Text] [Related]
30. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
[TBL] [Abstract][Full Text] [Related]
31. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
32. Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.
Marshall D; Pedley RB; Melton RG; Boden JA; Boden R; Begent RH
Br J Cancer; 1995 Jan; 71(1):18-24. PubMed ID: 7529526
[TBL] [Abstract][Full Text] [Related]
33. Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: theoretical and experimental pharmacokinetics.
Sung C; van Osdol WW; Saga T; Neumann RD; Dedrick RL; Weinstein JN
Cancer Res; 1994 Apr; 54(8):2166-75. PubMed ID: 8174124
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
[TBL] [Abstract][Full Text] [Related]
35. Immunotargeting of streptavidin to the pulmonary endothelium.
Muzykantov VR; Atochina EN; Gavriljuk V; Danilov SM; Fisher AB
J Nucl Med; 1994 Aug; 35(8):1358-65. PubMed ID: 8046494
[TBL] [Abstract][Full Text] [Related]
36. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
37. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
Sato N; Hassan R; Axworthy DB; Wong KJ; Yu S; Theodore LJ; Lin Y; Park L; Brechbiel MW; Pastan I; Paik CH; Carrasquillo JA
J Nucl Med; 2005 Jul; 46(7):1201-9. PubMed ID: 16000290
[TBL] [Abstract][Full Text] [Related]
38. Isothiocyanate-trigalactose: application for antibody-targeted delivery of diagnostic and therapeutic agents.
Rosebrough SF; Hartley DF
Cancer Biother Radiopharm; 2000 Oct; 15(5):507-15. PubMed ID: 11155822
[TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapy.
Goshorn S; Sanderson J; Axworthy D; Lin Y; Hylarides M; Schultz J
Cancer Biother Radiopharm; 2001 Apr; 16(2):109-23. PubMed ID: 11385958
[TBL] [Abstract][Full Text] [Related]
40. Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.
Demignot S; Pimm MV; Thorpe SR; Baldwin RW
Cancer Immunol Immunother; 1991; 33(6):359-66. PubMed ID: 1878889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
